SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-113174
Filing Date
2024-10-07
Accepted
2024-10-07 15:00:52
Documents
1
Period of Report
2024-10-07

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3582
  Complete submission text file 0000950170-24-113174.txt   4996
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 131 ESCANYO WAY PORTOLA VALLEY CA 94028
Business Address
Virsik Peter (Reporting) CIK: 0001826322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 241357558